期刊文献+
共找到3,517篇文章
< 1 2 176 >
每页显示 20 50 100
Hexagonal hematite platelets synthesized from pyrite cinders by hydrothermal process 被引量:3
1
作者 刘昭成 郑雅杰 《Journal of Central South University》 SCIE EI CAS 2011年第5期1377-1382,共6页
Well-crystallized hexagonal hematite (α-Fe2O3) platelets were synthesized by hydrothermal process, using a highly concentrated ferric hydroxide as precursor. The precursor was prepared by adding ammonia to the ferr... Well-crystallized hexagonal hematite (α-Fe2O3) platelets were synthesized by hydrothermal process, using a highly concentrated ferric hydroxide as precursor. The precursor was prepared by adding ammonia to the ferric sulfate solution which was obtained by leaching pyrite cinders with sulfuric acid. Structure and morphology of the synthesized products were investigated by X-ray diffraction, scanning electron microscope, transmission electron microscope and selected area electron diffraction. The results reveal that the reaction temperature has significant effects on the structure, size and shape of the synthesized hematite particles. Typical hexagonal hematite platelets, about 0.4-0.6 μm in diameter and 0.1 μm in thickness, were prepared at 230 ℃ for 0.5 h. Al^3+, contained in the sulfuric acid leaching solution as an impurity, plays an extremely important role in the formation of hexagonal hematite. In addition, a possible mechanism about the formation of hexagonal hematite platelets was proposed. 展开更多
关键词 HEMATITE Α-FE2O3 pyrite cinders hydrothermal process hexagonal platelets
在线阅读 下载PDF
Plasma pharmacological study on Da Huang Zhe Chong capsule on platelet aggregation of normal person 被引量:3
2
作者 WANG Dong-sheng CHEN Fang-ping XIAO Chang-jiang HE Shi-lin FU Bin LI Xin CAO Xing-yu CHEN Yan XIE Qin-zhi 《Journal of Central South University of Technology》 2005年第z1期326-330,共5页
Objective To develop a plasma pharmacological method evaluates the effect of Da Huang Zhe Chong capsule on platelet aggregation and its mechanism, which is a representative Traditional Chinese Medicine Patent Prescrip... Objective To develop a plasma pharmacological method evaluates the effect of Da Huang Zhe Chong capsule on platelet aggregation and its mechanism, which is a representative Traditional Chinese Medicine Patent Prescription Promoting blood circulation by removing blood stasis. Methods Platelets specimens from healthy volunteers made serum and plasma with medicine, while platelet PRP were separated, which were divided into 8groups,i.e. auto-serum, allo-serum, serum with Da Huang Zhe Chong capsule , serum with aspirin, auto-plasma, plasma with Da Huang Zhe Chong capsule, plasma with aspirin, every group added to serum and plasma to hatch. After ADP and adrenalin were added into the specimens and hatched, the effects of specimens on platelet aggregation were observed. Results After ADP adrenalin were added, all the serum groups did not present platelet aggregation,while all the plasma group presented platelet aggregation. P1, P5, Pmax, t and TM have no significant difference (P>0. 05) between auto-plasma group and allo-plasma group induced by ADP and adrenalin. P1, P5, t and Pmax have significant differences (P<0. 01) and TM decreased significantly (P<0. 05) comparing plasma group with Da Huang Zhe Chong capsule and plasma group of aspirin to allo-plasma group. P1, t and Pmax have significant difference (P<0.05), and P5 and TM are simulate comparing plasma group with Da Huang Zhe Chong capsule to plasma group of aspirin. P1, P5, t and Pmax have significant differences (P<0. 01), P1, TM have also significant(P<0. 05), comparing plasma group of Da Huang Zhe Chong capsule with plasma of aspirin to allo-plasma group induced by adrenalin. P1 ,P5 and Pmax have significant differences (P<0.05), and t and Pmax are simulate comparing plasma group with Da Huang Zhe Chong capsule with plasma group of aspirin. Conclusion The serum pharmacological study is inappropriate to study platelet aggregation in vitro. The plasma pharmacological study is inappropriate to study platelet aggregation in vitro. The plasma pharmacological study could reflect the pharmacological effect produced in vivo. Da Huang Zhe Chong capsule has better anti artery thrombosis effect than aspirin, and it is an ideal medicine for anti artery thrombosis. 展开更多
关键词 DA HUANG Zhe CHONG CAPSULE PLASMA pharmacology platelet aggregation
在线阅读 下载PDF
Nonlinear free vibration of graphene platelets reinforced composite corrugated plates 被引量:1
3
作者 LIU Yun-fei QIN Zhao-ye CHU Fu-lei 《Journal of Central South University》 SCIE EI CAS CSCD 2022年第9期3054-3064,共11页
The nonlinear vibration of graphene platelets reinforced composite corrugated(GPRCC)rectangular plates with shallow trapezoidal corrugations is investigated.Since graphene platelets are prone to agglomeration,a multi-... The nonlinear vibration of graphene platelets reinforced composite corrugated(GPRCC)rectangular plates with shallow trapezoidal corrugations is investigated.Since graphene platelets are prone to agglomeration,a multi-layer distribution is adopted here to match the engineering requirements.Firstly,an equivalent composite plate model is obtained,and then nonlinear equations of motion are derived by the von Kármán nonlinear geometric relationship and Hamilton’s principle.Afterwards,the Galerkin method and harmonic balance method are used to obtain an approximate analytical solution.Results show that the unit cell half period,unit cell inclination angle,unit cell height,graphene platelet dispersion pattern and graphene platelet weight fraction and geometry play important roles in the nonlinear vibration of the GPRCC plates. 展开更多
关键词 corrugated composite plate graphene platelets nonlinear vibration Galerkin method Harmonic balance method
在线阅读 下载PDF
Pharmacological actions of miltirone in the modulation of platelet function 被引量:1
4
作者 Zhang-yin MING Wei SONG 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2018年第4期252-253,共2页
OBJECTIVE Salvia miltiorrhiza bunge contains various active constituents,some of which have been developed as commercially available medicine.Moreover,some other ingredients in Salvia miltiorrhiza play great roles in ... OBJECTIVE Salvia miltiorrhiza bunge contains various active constituents,some of which have been developed as commercially available medicine.Moreover,some other ingredients in Salvia miltiorrhiza play great roles in anti-platelet activity.The aim of the present study was to investigate the effects and the underlying mechanism of miltirone,a lipophilic compound of Salvia miltiorrhiza Bunge.METHODS The ability of miltirone to modulate platelet function was investigated by a variety of in vitro and in vivo experiments.Platelet aggregation and dense granule secretion induced by various agonists were measured with platelet aggregometer.Clot retraction and spreading were imaged by digital camera and fl uorescence microscope.Ferric chloride-induced carotid injury model and pulmonary thromboembolism model were used to check miltirone effect in vivo.To elucidate the mechanisms of anti-platelet activity of miltirone,flow cytometry and Western blotting were performed.RESULTS Miltirone(2,4,8 μmol·L^(-1)) was shown to suppress platelet aggregation,dense granule and α granule secretion in a dose-dependent manner.Meanwhile,miltirone inhibited the clot retraction and spreading of washed platelets.It reduced the phosphorylation of PLCγ2,PKC,Akt,GSK3β and ERK1/2 in the downstream signal pathway of collagen receptor.It also reduced the phosphorylation of Src and FAK in the integrin αⅡbβ3 mediated "outside-in" signaling,while it did not suppress the phosphorylation of β3.In addition,miltirone prolonged the occlusion time and reduced collagen/epinephrine induced pulmonary thrombi.CONCLUSION Miltirone suppresses platelet "inside-out" and "outside-in" signaling by affecting PLCγ2/PKC/ERK1/2,PI3K/Akt and Src/FAK signaling.Therefore,miltirone might represent a potential anti-platelet candidate for the prevention of thrombotic disorders. 展开更多
关键词 miltirone anti platelet glycoproteinⅥpathway integrinαⅡbβ3
在线阅读 下载PDF
Components of traditional Chinese medicine inhibit platelet aggregation by blocking ADP receptor subtypes P2Y1 and P2Y12
5
作者 Xiao-liangWANG Yi-yingLI +2 位作者 Hong-yanYANG ShaofengXU LingWANG 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2015年第S1期28-29,共2页
Platelets aggregation and thrombosis formation are major reasons of cardiovascular and cerebral vascular diseases.To develop new generative,potent and safe agents for inhibiting platelet aggregation and preventing abo... Platelets aggregation and thrombosis formation are major reasons of cardiovascular and cerebral vascular diseases.To develop new generative,potent and safe agents for inhibiting platelet aggregation and preventing above diseases are urgently required.Some traditional Chinese medicines of″Houxue Huayu″have been shown to inhibit platelet aggregation potently.In the present study the mechanisms and the molecular targets of puerarin,salvianolic acid B and the analogue of 3-n-butylphthalide,dl-PHPB were investigated and compared with ticlopidine.Four platelet aggregation inducers,ADP,arachidonic acid,collagen and thrombin were used in the study.It was found that puerarin and dl-PHPB specifically inhibited ADP induced platelet aggregation like ticlopidine did.However,salvianolic acid B inhibited both ADP and collagen induced platelet aggregations with similar potency.Due to existing two ADP receptor subtypes on platelets,P2Y1 and P2Y12,we studied the action of above compounds on the receptors and the signaling pathways.It was found that dl-PHPB decreased IP1 accumulation produced by ADP,but had no effect on IP1 level induced by m-3M3 FBS,an activator of PLC.M-3M3 FBS might attenuate the inhibitory effect of dl-PHPB on ADP-induced platelet aggregation.In addition,dl-PHPB did not affect cyclic AMP formation in platelets by ADP,which is different from P2Y12 antagonist ticlopidine.Puerarin showed the similar effects of dl-PHPB.Therefore,the actions of dl-PHPB and puerarin might be through P2Y1receptor-PLC-βpathway.Salvianolic acid B did not reduce the IP1 accumulation stimulated by ADP.It might act on the receptor subtype P2Y12.Our results suggest that components of Chinese herb medicine might be a resource for development of novel anti-platelet drugs. 展开更多
关键词 platelet aggregation ADP RECEPTORS Houxue Huayu
在线阅读 下载PDF
OBSERVATION OF MEGAKARYOCYTOPOIESIS IN HUMAN FETUS BY IMMUNOCYTOCHEMICAL STAINING WITH ANTI-PLATELET GLYCOPROTEIN ⅡB /ⅢA MONOCLONAL ANTIBODY
6
作者 MA Dongchu CHU Junjie SUN Yinghui CHANG Kuizhong ZUO Wei (Department of Experimental Medicine, General Hospital of Shenyang Shenyang, China) Correspondence: Dr. MA Dongchu, Department of Experimental Medicine, General Hospital of Shenyang, 83, Wenhua Road, Shenyang, Liaoning 110015, China. 《中国实验血液学杂志》 CAS CSCD 1994年第2期197-204,共8页
Fetal liver tissues obtained from 28 human fetuses with gestation age from 3 to 6 months and fetal bone marrow from 35 human fetuses from 3 to 7 months were observed by immunochemical staining with anti-platelet GPⅡ ... Fetal liver tissues obtained from 28 human fetuses with gestation age from 3 to 6 months and fetal bone marrow from 35 human fetuses from 3 to 7 months were observed by immunochemical staining with anti-platelet GPⅡ b / Ⅲa monoclonal antibody and ABC technique. In the fetal liver, megakaryocytes were wholly located among growing fetal liver cells and near foci of hemopoiesis. Some megakaryocytes in the fetal liver were small7890- lymphoid-like megakaryocytes. The size of megakaryocytes both in the fetal liver (14.79 ± 4.52μm) and in the fetal bone marrow (16.08±7.39 μm) was small, which did not vary significantly over the gestation age ranging from 3 to 6 or 7 months. However, the maturation stage of megakaryocytes in the fetal liver shifted to more mature stage with the advancement of gestation, although the maturation stage of megakaryocytes in the fetal bone marrow did not change with the advancement of gestation from 4 to 7 months, the megakaryocyte in the fetal bone marrow was less mature 展开更多
关键词 MEGAKARYOCYTE anti- platelet GP b / a monoclonal anti- body immunocytochemical STAINING
在线阅读 下载PDF
Effects of hydrogen-rich saline on platelet activation in hypertensive rats
7
作者 HE Ke-gui WANG Yun +6 位作者 MIN Xiang-dong HAN Ji-ju JIAO Peng CHEN Xiu-yu CAO Cheng-bao GONG Min ZHAO Xiao-min 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2016年第10期1006-1007,共2页
OBJECTIVE To investigate the effect of hydrogen-rich saline on platelet activation in hypertensive rats.METHODS The male Wistar rats were divided into control group,hypertension group,control+hydrogen-rich saline grou... OBJECTIVE To investigate the effect of hydrogen-rich saline on platelet activation in hypertensive rats.METHODS The male Wistar rats were divided into control group,hypertension group,control+hydrogen-rich saline group and hypertension+hydrogen-rich saline group.Hypertension was induced by subcutaneous infusion with angiotensinⅡ0.7 mg·kg-1·d-1for 2 weeks by osmotic mini-pumps in rats.Hydrogen-rich saline(10 mL·kg-1·d-1)was administered by intraperitoneal injection for 14 d.Platelet adhesion on collagen surface was evaluated using a well-defined perfusion chamber at low shear rate(300s-1)and high shear rate(1080s-1).The maximum aggregation rate of platelets induced by ADP was determined by turbidimetry.The levels of reactive oxygen species(ROS),nitric oxide(NO)and Ca2+in platelets were measured with flow cytometry.RESULTS When compared with the control group,platelet aggregation,platelet adhesion rate in high shear rate and low shear rate,and the level of ROS and Ca2+in platelets were elevated in hypertensive group.However,NO level in platelets decreased.Compared with the hypertensive group,hydrogen-rich saline treatment decreased platelet aggregation,platelet adhesion rate,the levels of ROS and Ca2+in platelets,and increased NO level in platelets of hypertensive rats.CONCLUSION Hydrogen-rich saline could inhibit platelet activation in hypertensive rats.This effect may be related to antioxidative stress. 展开更多
关键词 HYPERTENSION platelet activation HYDROGEN oxidative stress
在线阅读 下载PDF
Screening of active ingredients of Taohong Siwu Decoction on platelet membrane receptor
8
作者 GUO Chun-yan WU Xin +2 位作者 CHEN Shuang GAO Yuan-yuan WAN Ye 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2017年第5期483-484,共2页
OBJECTIVE To screen the active ingredients preventing platelet aggregations from Taohong Siwu Decoction. METHODS Fresh blood from healthy adult volunteer was collected with vacuum tube for preparation of platelet susp... OBJECTIVE To screen the active ingredients preventing platelet aggregations from Taohong Siwu Decoction. METHODS Fresh blood from healthy adult volunteer was collected with vacuum tube for preparation of platelet suspension. Platelet suspension was incubated with Taohong Siwu Decoction for one hour at 37℃,then centrifuged. The precipitate was washed and desorbed with buffer solutions.The differences of chemical constituents between incubated and unincubated were identified with high performance liquid chromatography-diode array detector. RESULTS According to the chromatograph at 254 nm,at least three kinds of different components were detected in Taohong siwu decoction before and after incubated with platelet. CONCLUSION Platelet suspension can be used for screening active ingredients on platelet membrane receptor from the traditional Chinese medicine. 展开更多
关键词 Taohong Siwu Decoction blood platelet HPLC DAD
在线阅读 下载PDF
Time-effect and dose-effect of prasugrel hydrobromide acetic acid compound inhibiting platelet aggregation
9
《中国药理学通报》 CAS CSCD 北大核心 2015年第B11期178-178,共1页
Aim To evaluate the time-effect and dose-effect of prasugrel hydrobromide acetic acid compound (PHAAC) inhibiting platelet aggregation. Methods For the time-effect study, 190 Sprague-Dawley (SD) rats were devided ... Aim To evaluate the time-effect and dose-effect of prasugrel hydrobromide acetic acid compound (PHAAC) inhibiting platelet aggregation. Methods For the time-effect study, 190 Sprague-Dawley (SD) rats were devided into 19 groups (n- 10): the vehicle control group, the PHAAC groups (0.5, 1, 2, 4, 6, 24, 48, 72, 96 h) and the prasugrel hydrochloride groups (0.5, 1, 2, 4, 6, 24, 48, 72, 96 h). Rats were singly intra- gastic administration of the vehicle, the PHAAC (5 mg·kg^-1) or the prasugrel hydrochloride (5 mg · kg^-1 ), re- spectively. Blood samples were taken at each time point for the determination of platelet aggregation rate (PAR). For the dose-effect study, 110 SD rats were devided into 11 groups (n= 10): the vehicle control group, the PHAAC groups (10, 5, 2.5, 1, 0.5 mg · kg^-1, dosage of prasugrel) and the prasugrel hydrochloride groups ( 10, 5, 2.5, 1, 0.5 mg · kg^-1, dosage of prasugrel) . Blood samples were taken at 4 h after drug administration for the determination of PAR. Results Compared with the vehicle group, PHAAC has significant anti-platelet ag- gregative effects (P 〈 0.05) at the time of 0.5, 1, 2, 4, 6, 24, 48 h, and the effect at the time of 4 h was the strongest. There were no obvious differences between the effect of PHAAC (5 mg · kg^-1) and prasugrel hydrochlo- ride (5 mg · kg^-1) at each time point. Compared with the vehicle group, intragastic administration of PHAAC at the doses of 10, 5, 2.5, 1, 0.5 mg · kg^-1 could obviously inhibite the platelet aggregation, and showed a dose- dependent manner. There were no significant differences between the effect of PHAAC and prasugrel hydrochloride at the same dose. Conclusion PHAAC can inhibit platelet aggregation in a dose-dependent manner, and the effect at 4 h after drug administration is the strongest. The action strength and duration of PHAAC are similar with that of the prasugrel hydrochloride. 展开更多
关键词 PRASUGREL hydrobromide acetic acid compound platelet aggregation time-effect DOSE-EFFECT prasug-rel HYDROCHLORIDE
在线阅读 下载PDF
Platelet reactivity and clinical outcome in patients with renal insufficiency undergoing percutaneous coronary intervention
10
作者 Pei Zhu Xiaofang Tang +10 位作者 Jingjing Xu Ying Song Yin Zhang Lei Song Lijian Gao Zhan Gao Jue Chen Yuejin Yang Runlin Gao Bo Xu Jinqing Yuan 《中国循环杂志》 CSCD 北大核心 2018年第S01期146-146,共1页
Background and Objective Renal insufficiency(RI)is reported to be associated with increased ischemic and bleeding events after percutaneous coronary intervention(PCI),which is possibly due to high residual platelet re... Background and Objective Renal insufficiency(RI)is reported to be associated with increased ischemic and bleeding events after percutaneous coronary intervention(PCI),which is possibly due to high residual platelet reactivity(HRPR)during DAPT therapy.Therefore,we performed a large prospective observational study to evaluate the platelet reactivity and related clinical outcomes in real-world patients with different renal insufficiency stage after PCI,and to examine whether HRPR is associated with higher incidence of adverse cardiovascular events in a 2-year follow up. 展开更多
关键词 RENAL INSUFFICIENCY PERCUTANEOUS CORONARY intervention high residual platelet reactivity
在线阅读 下载PDF
Usefulness of white blood cell count to mean platelet volume ratio for predicting long-term prognosis after primary percutaneous coronary intervention in patients with acute coronary syndrome
11
作者 Na Xu Xiaofang Tang +9 位作者 Yi Yao Jingjing Xu Ying Song Ru Liu Ping Jiang Lin Jiang Yuejin Yang Runlin Gao Bo Xu Jinqing Yuan 《中国循环杂志》 CSCD 北大核心 2018年第S01期133-133,共1页
Background and Objective The white blood cell count to mean platelet volume ratio(WMR)has recently been described as a predictor of cardiovascular events in patients who undergo percutaneous coronary intervention(PCI)... Background and Objective The white blood cell count to mean platelet volume ratio(WMR)has recently been described as a predictor of cardiovascular events in patients who undergo percutaneous coronary intervention(PCI).The aim of this study was to investigate the usefulness of admission WMR in predicting outcomes in patients with acute coronary syndrome(ACS). 展开更多
关键词 white blood cell COUNT to mean platelet volume RATIO PERCUTANEOUS CORONARY intervention acute CORONARY syndrome
在线阅读 下载PDF
Bending and stress analysis of polymeric composite plates reinforced with functionally graded graphene platelets based on sinusoidal shear-deformation plate theory
12
作者 Mohammad Arefi Ali Tabatabaeian Masoud Mohammadi 《Defence Technology(防务技术)》 SCIE EI CAS CSCD 2021年第1期64-74,共11页
The bending and stress analysis of a functionally graded polymer composite plate reinforced with graphene platelets are studied in this paper.The governing equations are derived by using principle of virtual work for ... The bending and stress analysis of a functionally graded polymer composite plate reinforced with graphene platelets are studied in this paper.The governing equations are derived by using principle of virtual work for a plate which is rested on Pasternak’s foundation.Sinusoidal shear deformation theory is used to describe displacement field.Four different distribution patterns are employed in our analysis.The analytical solution is presented for a functionally graded plate to investigate the influence of important parameters.The numerical results are presented to show the deflection and stress results of the problem for four employed patterns in terms of geometric parameters such as number of layers,weight fraction and two parameters of Pasternak’s foundation. 展开更多
关键词 Reinforced composite plate Graphene platelet Sinusoidal shear deformation theory Pasternak’s foundation Stress and deformation analysis
在线阅读 下载PDF
Vascular dysfunctions and platelet activations by arsenic: two major contributing factors to cardiovascular disease
13
作者 JH CHUNG 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2006年第3期164-164,共1页
Arsenic in drinking water is a worldwide health problem that is associated with cardiovascular disease, but the cause is currently unknown. In order to examine whether arsenic affects vasomotor tone in blood vessels, ... Arsenic in drinking water is a worldwide health problem that is associated with cardiovascular disease, but the cause is currently unknown. In order to examine whether arsenic affects vasomotor tone in blood vessels, we investigated the effect of arsenic on agonist-induced vasorelaxation and vasoconstriction using the isolated rat aortic rings in in vitro organ bath system. Treatment with inorganic arsenite (AsⅢ) inhibited acetylcholine-induced relaxation of aortic rings by inhibiting production of nitric oxide in endothelium. 展开更多
关键词 Vascular dysfunctions and platelet activations by arsenic two major contributing factors to cardiovascular disease
在线阅读 下载PDF
Platelet adhesion to the surface of a sudden tubular expansion tube under swirling flow condition
14
作者 Fan ZHAN,Xiaoyan DENG,Yubo FAN(School of Biological Science&Medical Engineering,Beihang University,Beijing,100191,China) 《医用生物力学》 EI CAS CSCD 2009年第S1期22-22,共1页
The size mismatch in an end-to-end vascular anastomosis between the host vessel and the graft may cause flow disturbance and predispose to thrombosis [1].Although a number of techniques have been employed to reduce th... The size mismatch in an end-to-end vascular anastomosis between the host vessel and the graft may cause flow disturbance and predispose to thrombosis [1].Although a number of techniques have been employed to reduce the risk of anastomotic thrombosis due to the size mismatch。 展开更多
关键词 flow platelet adhesion to the surface of a sudden tubular expansion tube under swirling flow condition
在线阅读 下载PDF
不同剂量替格瑞洛治疗ST段抬高型心肌梗死患者的有效性和安全性:基于倾向性评分匹配 被引量:4
15
作者 汪雁博 苏利芳 +5 位作者 刘畅畅 周庆 田佳 支伟 傅阳 谷新顺 《中国全科医学》 CAS 北大核心 2025年第3期372-378,共7页
背景双联抗血小板治疗是接受直接经皮冠状动脉介入治疗(PPCI)的ST段抬高型心肌梗死(STEMI)患者治疗的基础。阿司匹林联合替格瑞洛是STEMI患者抗血小板治疗的首选方案,与氯吡格雷相比,其能够更快、更有效地抑制血小板,并改善预后。但是... 背景双联抗血小板治疗是接受直接经皮冠状动脉介入治疗(PPCI)的ST段抬高型心肌梗死(STEMI)患者治疗的基础。阿司匹林联合替格瑞洛是STEMI患者抗血小板治疗的首选方案,与氯吡格雷相比,其能够更快、更有效地抑制血小板,并改善预后。但是尚缺乏在接受PPCI治疗的STEMI患者中应用减量替格瑞洛的研究。目的基于倾向性评分匹配(PSM)的方法,对比分析不同剂量替格瑞洛治疗STEMI患者的有效性和安全性。方法连续选取2019年6月—2021年5月在河北医科大学第二医院心血管内五科行PPCI并接受替格瑞洛治疗的STEMI患者为研究对象。根据应用替格瑞洛的维持剂量将患者分为减量组(60例:替格瑞洛60 mg/次,2次/d)和标准组(180例:替格瑞洛90 mg/次,2次/d)。采用PSM法对两组患者进行1∶1匹配,匹配变量包括性别、年龄、既往病史、入院时Killip分级和介入治疗相关参数等,最终减量组和标准组各纳入54例患者。分别于出院1、3、6个月时,对两组患者进行随访,记录和比较两组患者血小板功能相关参数和临床事件的发生情况。结果PSM后两组患者基线资料、介入治疗参数和住院期间主要不良心血管事件发生率比较,差异均无统计学意义(P>0.05)。基线时,两组患者血小板计数(PLT)、平均血小板体积(MPV)、血小板分布宽度(PDW)比较,差异均无统计学意义(P>0.05);减量组患者血小板聚集率(PAR)低于标准组(P<0.05)。出院时,减量组患者MPV高于标准组,PDW低于标准组(P<0.05)。出院1个月时,两组患者PLT、MPV、PDW、PAR比较,差异均无统计学意义(P>0.05)。出院3个月时,减量组患者PDW高于标准组(P<0.05)。出院6个月时,减量组患者MPV高于标准组(P<0.05)。减量组患者出院前后PLT、PAR比较,标准组患者出院前后PLT、PDW比较,差异均无统计学意义(P>0.05)。减量组、标准组患者出院时MPV高于基线,减量组患者出院时PDW低于基线,标准组患者出院时PAR低于基线(P<0.05)。减量组患者出院1、3、6个月MPV低于出院时,PDW高于出院时(P<0.05);标准组患者1、3、6个月PAR低于基线,高于出院时(P<0.05)。两组患者随访期间主要不良心血管事件、严重出血事件发生率比较,差异均无统计学意义(P>0.05)。结论在接受PPCI的STEMI患者中替格瑞洛60 mg治疗是安全有效的。 展开更多
关键词 ST段抬高型心肌梗死 经皮冠状动脉介入治疗 替格瑞洛 血小板 主要不良心血管事件 倾向性评分匹配
在线阅读 下载PDF
平均血小板体积与维持性血液透析患者血管通路事件的相关性研究 被引量:2
16
作者 朱荣芳 靳晶晶 +4 位作者 梁向楠 钱玥彤 耿同会 白亚玲 徐金升 《中国全科医学》 北大核心 2025年第15期1855-1861,共7页
背景动静脉内瘘是维持性血液透析(MHD)患者的主要血管通路。平均血小板体积(MPV)是心血管事件的生物标志物,MPV已被确定为心肌梗死、中风和静脉血栓栓塞的独立危险因素。MPV是否是MHD患者发生血管通路事件的危险因素尚不明确。目的探讨... 背景动静脉内瘘是维持性血液透析(MHD)患者的主要血管通路。平均血小板体积(MPV)是心血管事件的生物标志物,MPV已被确定为心肌梗死、中风和静脉血栓栓塞的独立危险因素。MPV是否是MHD患者发生血管通路事件的危险因素尚不明确。目的探讨MPV水平与MHD患者血管通路事件风险的相关性。方法选取2020-09-01—15在河北医科大学第四医院血液净化中心行MHD的患者343例为研究对象。随访截止时间为2021-09-15,终点事件为出现血管通路事件(动静脉内瘘狭窄或血栓)或患者出现死亡。根据纳入患者MPV值的四分位数将患者分为4组:Q1组(MPV:6.1~8.1 fL),Q2组(MPV:8.2~8.8 fL),Q3组(MPV:8.9~9.6 fL),Q4组(MPV:9.7~14.1 fL)。比较4组MHD患者一般情况、实验室检查、动静脉内瘘血栓及狭窄的发病率等相关资料。采用Kaplan-Meier生存曲线分析MHD患者血管通路事件发生率,组间比较采用Log-rank检验。使用多重Cox比例风险回归模型分析MHD患者MPV与血管通路事件风险之间的相关性,并进一步根据分层特征进行亚组分析。结果343例MHD患者中60(17.5%)例患者出现血管通路事件,Q4、Q3、Q2、Q1组MHD患者血管通路事件的发生率分别为33.7%(29/86)、17.8%(16/90)、12.2%(10/82)、5.9%(1/85)。Kaplan-Meier生存曲线分析结果显示,4组MHD患者血管通路事件发生率比较,差异有统计学意义(χ^(2)=25.691,P<0.05)。校正混杂因素后,MPV水平升高仍是MHD患者血管通路事件发生风险的危险因素(HR=1.59,95%CI=1.28~1.97,P<0.001),且随着MPV水平升高MHD患者血管通路事件发生风险增加(P_(趋势)<0.001)。亚组分析结果显示,除糖尿病分组,其他各亚组间均不存在交互作用(P_(交互)>0.05)。结论MPV水平升高可能是MHD患者血管通路事件发生风险的危险因素,为临床医生预测血管通路事件发生的风险提供了参考指标。 展开更多
关键词 血液透析 维持性血液透析 平均血小板体积 血管通路事件 动静脉内瘘
在线阅读 下载PDF
95987例住院患者血小板抗体筛查临床价值分析 被引量:1
17
作者 陈萍 孙杨 +8 位作者 褚晓月 田芬芳 杨颖群 王文华 牛佳萌 赵柏雅 常婧妍 杨江存 马超锋 《细胞与分子免疫学杂志》 北大核心 2025年第2期143-147,共5页
目的分析血小板抗体在住院患者中的分布情况,探讨血小板抗体检测的临床意义。方法收集2021-04-01/2023-12-31西安地区某三级医院住院患者95987例,采用固相凝集法检测血小板抗体。对其在性别、年龄、血型、科室、输血史、妊娠史及疾病类... 目的分析血小板抗体在住院患者中的分布情况,探讨血小板抗体检测的临床意义。方法收集2021-04-01/2023-12-31西安地区某三级医院住院患者95987例,采用固相凝集法检测血小板抗体。对其在性别、年龄、血型、科室、输血史、妊娠史及疾病类型等方面进行统计分析。结果95987例住院患者中,血小板抗体检测阳性率达4.35%,女性住院患者血小板抗体阳性率(5.29%)高于男性患者(3.31%),差异有统计学意义(χ^(2)=224.124)。有妊娠史的血小板抗体阳性率(7.92%)高于无妊娠史(4.19%),差异显著(χ^(2)=292.773);同样,有输血史血小板抗体阳性率(7.79%)高于无输血史(3.97%),差异显著(χ^(2)=300.209)。血小板抗体阳性率与妊娠次数呈现显著相关性(χ^(2)=91.061)。结论95987例住院患者血小板抗体阳性率为4.35%,血小板抗体阳性率与输血史及妊娠史有着密切关系,并随着妊娠次数的增加而增加,对于有多次输血史及妊娠史的患者来说,血小板抗体筛查具有重要的诊断价值。 展开更多
关键词 血小板抗体 血小板输注无效 住院患者
在线阅读 下载PDF
不同抗血小板聚集治疗方案对颅内破裂宽颈动脉瘤急性期行LVIS支架辅助弹簧圈栓塞患者的临床疗效分析 被引量:1
18
作者 李文帅 赵亚运 +5 位作者 郭震 张海兵 王奉淼 张信芳 张全忠 李庆民 《中国脑血管病杂志》 北大核心 2025年第5期302-309,共8页
目的比较术中静脉应用替罗非班与术前负荷量双联抗血小板聚集治疗在颅内破裂宽颈动脉瘤急性期行LVIS支架辅助弹簧圈栓塞患者中的临床疗效。方法回顾性连续纳入2017年1月至2023年6月菏泽市立医院神经外科收治的颅内破裂宽颈动脉瘤急性期... 目的比较术中静脉应用替罗非班与术前负荷量双联抗血小板聚集治疗在颅内破裂宽颈动脉瘤急性期行LVIS支架辅助弹簧圈栓塞患者中的临床疗效。方法回顾性连续纳入2017年1月至2023年6月菏泽市立医院神经外科收治的颅内破裂宽颈动脉瘤急性期应用LVIS支架辅助弹簧圈栓塞治疗的患者。根据《颅内动脉瘤抗血小板治疗中国专家共识》指导下患者实际接受的抗血小板聚集治疗方案将所有患者分为负荷量双抗组和替罗非班组。收集并比较两组患者的基线及临床资料,包括年龄、性别、高血压病、糖尿病、冠心病、既往脑出血、术前Hunt-Hess分级、动脉瘤最大径、瘤颈宽度及动脉瘤部位。收集并比较两组患者围手术期缺血性与出血性并发症发生情况。围手术期缺血性并发症包括术中支架内血栓形成(定义为术中载瘤动脉内充盈缺损,载瘤动脉或支架覆盖分支血管闭塞)及术后24 h内症状性脑梗死。围手术期出血性并发症包括术中责任动脉瘤破裂出血和术后24 h内颅内出血(CT发现新的或恶化的蛛网膜下腔出血或脑实质内出血)。采用改良Rankin量表(mRS)电话或门诊随访评估患者术后90 d预后情况,mRS评分0~2分为预后良好,3~6分为预后不良。术后6个月行影像学随访,将与术后即刻栓塞结果相比的随访结果分为4类:(1)完全闭塞,即动脉瘤腔内对比剂填充完全消失;(2)改善,即动脉瘤腔内对比剂填充减少;(3)稳定,即动脉瘤腔内对比剂填充保持不变;(4)复发,即动脉瘤腔内对比剂填充增加。结果共纳入颅内破裂宽颈动脉瘤急性期行LVIS支架辅助弹簧圈栓塞患者108例,男30例,女78例,年龄32~75岁,中位年龄63(50,66)岁;其中负荷量双抗组55例,替罗非班组53例。(1)替罗非班组与负荷量双抗组各基线及临床资料差异均无统计学意义(均P>0.05)。(2)所有患者均成功实施LVIS支架辅助弹簧圈栓塞治疗,技术成功率为100%。总体围手术期缺血性并发症发生率为12.0%(13/108),其中术中支架内血栓形成发生率为4.6%(5/108),术后24 h内症状性脑梗死发生率为7.4%(8/108);总体围手术期出血性并发症发生率为1.9%(2/108),包括1例术中责任动脉瘤破裂出血和1例术后24 h内颅内出血。92.6%(100/108)的患者术后90 d随访预后良好,7.4%(8/108)的患者预后不良。78.7%(85/108)的患者完成术后6个月影像学随访,其中完全闭塞率为94.1%(80/85),复发率为2.4%(2/85)。(3)替罗非班组和负荷量双抗组患者围手术期缺血性并发症总体发生率分别为13.2%(7/53)和10.9%(6/55),组间差异无统计学意义(P=0.720)。负荷量双抗组术中支架内血栓形成发生率高于替罗非班组[9.1%(5/55)比0,P=0.025],术后24 h内症状性脑梗死发生率低于替罗非班组[1.8%(1/55)比13.2%(7/53),P=0.028]。负荷量双抗组围手术期出血性并发症总体发生率为3.6%(2/55),替罗非班组未发生围手术期出血性并发症。术后90 d随访结果显示,替罗非班组和负荷量双抗组良好预后比例分别为94.3%(50/53)和90.9%(50/55),组间差异无统计学意义(P=0.754)。结论术中静脉应用替罗非班与术前负荷量双抗两种方案对颅内破裂宽颈动脉瘤急性期行LVIS支架辅助弹簧圈栓塞患者均具有一定的安全性和良好的临床效果。本研究结果尚需大型前瞻性研究验证。 展开更多
关键词 颅内动脉瘤 动脉瘤 破裂 替罗非班 双重抗血小板聚集治疗 LVIS支架
在线阅读 下载PDF
铅基织构压电陶瓷的发展历程、现状与挑战 被引量:1
19
作者 吴杰 杨帅 +3 位作者 王明文 李景雷 李纯纯 李飞 《无机材料学报》 北大核心 2025年第6期575-586,共12页
压电材料是一种重要的信息功能材料,能够实现机械能与电能之间的相互转化。近年来,织构压电陶瓷技术已经成为研发新一代高性能压电材料的重要途径。通过调控晶粒的取向排布,织构压电陶瓷表现出类似压电单晶的优异压电性能和机电性能,并... 压电材料是一种重要的信息功能材料,能够实现机械能与电能之间的相互转化。近年来,织构压电陶瓷技术已经成为研发新一代高性能压电材料的重要途径。通过调控晶粒的取向排布,织构压电陶瓷表现出类似压电单晶的优异压电性能和机电性能,并具有良好的温度稳定性。同时,作为多晶陶瓷,织构陶瓷保留了传统陶瓷材料的制备加工简单、机械性能良好及适用共型异形等优点。本文围绕钛酸铅(PbTiO_(3),PT)基压电材料体系,从织构压电陶瓷制备技术、织构用籽晶模板以及织构压电陶瓷技术的发展历程和研究现状等方面,对相关研究结果进行系统梳理,总结织构压电陶瓷技术优势。在此基础上,分析了铅基织构压电陶瓷的模板筛选理论、织构陶瓷微观结构和宏观性能之间的构效关系,以及基于织构压电陶瓷的压电器件开发等方面存在的科学难题和未来挑战。本文旨在全面介绍织构压电陶瓷技术和理论,帮助研究者深入认识织构压电陶瓷技术,推动高性能压电陶瓷研发和制备技术发展,进而助力我国高端压电器件的创新和跨越发展。 展开更多
关键词 织构陶瓷 铅基压电材料 模板籽晶生长法 片状微晶模板 综述
在线阅读 下载PDF
富血小板血浆治疗轻中度斑秃有效性和安全性的系统评价
20
作者 宋黎 陆茂 +1 位作者 唐懿 刘彦麟 《临床皮肤科杂志》 北大核心 2025年第7期402-407,共6页
目的:评价富血小板血浆治疗轻中度斑秃的有效性和安全性。方法:计算机检索截至2024年6月The Cochrane Library、PubMed、Web of Science、EMbase、中国知网(CNKI)、万方数据知识服务平台、维普中文期刊服务平台、中国生物医学文献服务系... 目的:评价富血小板血浆治疗轻中度斑秃的有效性和安全性。方法:计算机检索截至2024年6月The Cochrane Library、PubMed、Web of Science、EMbase、中国知网(CNKI)、万方数据知识服务平台、维普中文期刊服务平台、中国生物医学文献服务系统(SinoMed)中关于富血小板血浆治疗斑秃的随机对照试验(RCT),手工检索补全可能的研究。经2名独立研究人员筛选出纳入的研究并进行文献质量评价,最后对纳入研究采用RevMan 5.3软件进行Meta分析,不能Meta分析的资料采用描述性分析。结果:共纳入9项RCT研究,413例患者。Meta分析结果显示:(1)富血小板血浆组与曲安奈德组治疗斑秃有效率的差异无统计学意义(OR=1.22,95%CI=0.43~3.50,n=247,P>0.05);(2)富血小板血浆组斑秃复发风险低于曲安奈德组(OR=0.18,95%CI=0.08~0.39,n=125,P<0.05);(3)富血小板血浆组主要不良反应是疼痛,其发生率与曲安奈德组比较差异无统计学意义(OR=1.80,95%CI=0.28~11.72,n=202,P>0.05),2组均无严重不良反应发生。结论:目前证据显示富血小板血浆可有效促进轻中度斑秃患者的毛发生长,可能出现疼痛等不良反应,但总体较安全。 展开更多
关键词 富血小板血浆 斑秃 系统评价 Meta分析 毛发镜
在线阅读 下载PDF
上一页 1 2 176 下一页 到第
使用帮助 返回顶部